MBX 2109 for Hypoparathyroidism Earns Orphan Drug Designation
In the U.S., the FDA grants Orphan Drug designation to drugs or biologics intended to treat, diagnose, or prevent rare diseases or conditions. “Rare” refers to any condition affecting fewer…